Cornerstone Financial Management’s BioAge Labs BIOA Stock Holding History
Bought
Maintained
Sold
Other funds holding BIOA
Cornerstone Financial Management's BIOA Position: Q3 2026 in Review
Cornerstone Financial Management held its BioAge Labs (BIOA) position steady in Q3 2026 at 110 shares worth $780. The position accounts for ﹤0.01% of the portfolio, ranked #1262.
Cornerstone Financial Management first reported a position in BIOA in Q4 2025 and has held it in 4 quarters since. The position peaked at $2.7K in Q2 2026. 162 funds tracked by Wall St. Rank hold BIOA as of Q3 2026.
- Cornerstone Financial Management held 110 shares of BioAge Labs worth $780 as of Q3 2026.
- Cornerstone Financial Management left its BioAge Labs share count unchanged in Q3 2026.
- BioAge Labs made up ﹤0.01% of Cornerstone Financial Management's portfolio in Q3 2026, its #1262 holding.
- Cornerstone Financial Management first reported a position in BioAge Labs in Q4 2025 and has held it in 4 quarters since.
- Cornerstone Financial Management's BioAge Labs position peaked at $2.7K in Q2 2026.
- 162 funds tracked by Wall St. Rank held BioAge Labs as of Q3 2026.
Based on Cornerstone Financial Management's 13F filing for Q3 2026, filed 10 Nov 2026.